Trial Profile
A Randomized, Double Blind, Multi-center, Active Drug Controlled Clinical Trial to Compare the Efficacy and Safety of MEDITOXIN Versus BOTOX in Treatment of Post Stroke Upper Limb Spasticity
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Mar 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Sponsors Medytox
- 11 Dec 2014 New trial record